How to Detect Chromosomal Alterations in Plastma
All cancer patients, no matter the primary site, have abnormal chromosomes released from [MORE]
When will DNA sequencing become a common option in clinical medicine? With most healthcare providers that may be a [MORE]
This piece is best summarized in its own words: “For the first time, researchers from Cambridge have used DNA sequencing [MORE]
Stem Cell Mutations
At least since 1971, when Alfred Knudson proposed the “multiple hit” theory for the origin of cancers, [MORE]
Knome DNA Decoder
The greatest constriction of clinical genomics no longer is the cost of DNA sequencing as much as [MORE]
Human Microbiome Project
With $170m funding some 200 scientists at 80 institutions, the has sought to identify a [MORE]
In a paper titled “Systematic Identification of Genomic Markers of Drug Sensitivity in Cancer Cells,” a research group from [MORE]
Electrical Signals from DNA Nano Sequencer
Technical developments in DNA sequencing tend to have a “forward-looking” character that some might [MORE]
It is common knowledge that it’s better to catch cancer in an early state than later. The reason is that [MORE]
ITOR gene sequencing chip
2012 is a big year for South Carolina’s Greenville Hospital System: it celebrates its centennial as [MORE]
Spartan 1 Bedside Genetic Tester
While whole-genome sequencing is moving in the right directions (better results, lower costs), it still [MORE]
Whole Exome Sequencing
For cost reasons, exome sequencing—i.e. sequencing the protein coding sections of the genome—may precede whole genome sequencing [MORE]
While a year ago, the FDA put a hold on companies selling genomic kits directly to consumers, researchers are [MORE]
Genome Sequencing
DNA sequencing is a necessary, but not entirely sufficient step, toward personalized medicine. Providers have to figure out how [MORE]